IT202200002000A1 - Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale - Google Patents

Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale Download PDF

Info

Publication number
IT202200002000A1
IT202200002000A1 IT102022000002000A IT202200002000A IT202200002000A1 IT 202200002000 A1 IT202200002000 A1 IT 202200002000A1 IT 102022000002000 A IT102022000002000 A IT 102022000002000A IT 202200002000 A IT202200002000 A IT 202200002000A IT 202200002000 A1 IT202200002000 A1 IT 202200002000A1
Authority
IT
Italy
Prior art keywords
active ingredient
oral composition
poorly absorbable
intestinal level
liposomal
Prior art date
Application number
IT102022000002000A
Other languages
English (en)
Inventor
Massimo Chimenti
Original Assignee
Mak Pharma S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mak Pharma S R L filed Critical Mak Pharma S R L
Priority to IT102022000002000A priority Critical patent/IT202200002000A1/it
Publication of IT202200002000A1 publication Critical patent/IT202200002000A1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
IT102022000002000A 2022-02-04 2022-02-04 Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale IT202200002000A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102022000002000A IT202200002000A1 (it) 2022-02-04 2022-02-04 Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000002000A IT202200002000A1 (it) 2022-02-04 2022-02-04 Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale

Publications (1)

Publication Number Publication Date
IT202200002000A1 true IT202200002000A1 (it) 2023-08-04

Family

ID=81648824

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000002000A IT202200002000A1 (it) 2022-02-04 2022-02-04 Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale

Country Status (1)

Country Link
IT (1) IT202200002000A1 (it)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265116B1 (en) * 1986-10-13 1998-03-11 FIDIA S.p.A. Cross-linked esters of hyaluronic acid
CA3025208A1 (en) * 2016-05-24 2017-11-30 Bol Pharma Ltd. Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
WO2018138221A1 (en) * 2017-01-26 2018-08-02 Beauty System Pharma S.R.L. Hyaluronic acid cross-linked with natural or semi-synthetic crosslinking agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265116B1 (en) * 1986-10-13 1998-03-11 FIDIA S.p.A. Cross-linked esters of hyaluronic acid
CA3025208A1 (en) * 2016-05-24 2017-11-30 Bol Pharma Ltd. Compositions comprising cannabidiol and hyaluronic acid for treating inflammatory joint diseases
WO2018138221A1 (en) * 2017-01-26 2018-08-02 Beauty System Pharma S.R.L. Hyaluronic acid cross-linked with natural or semi-synthetic crosslinking agents

Similar Documents

Publication Publication Date Title
DE50212546D1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
CL2004000382A1 (es) Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6.
MA55557A (fr) Formes solides d'un inhibiteur de bêta-lactamases administré par voie orale et leurs utilisations
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
EA202190621A1 (ru) Фармацевтическая композиция, содержащая антитромбоцитарное средство и ингибитор секреции желудочной кислоты
IT202200002000A1 (it) Composizione orale liposomiale di almeno un principio attivo scarsamente assorbibile a livello intestinale
ECSP055625A (es) Profarmaco inhibidor de beta-lactamasa
ES2981041T3 (es) Formulación oral sólida de utidelona
MX2020008230A (es) Derivados de ester butanoico sustituido con bisfenilo como inhibidores de nep.
JP1772017S (ja) タオル
JP1770478S (ja) 衛生マスク
JP1770477S (ja) 衛生マスク
JP1762594S (ja) 衛生マスク
JP1762595S (ja) 衛生マスク
JP1740191S (ja) 衛生マスク
JP1735670S (ja) 衛生マスク
JP1730756S (ja) 衛生用マスク
JP1725778S (ja) 衛生用マスク
JP1725739S (ja) 衛生用マスク
JP1725738S (ja) 衛生用マスク
JP1723540S (ja) 衛生用マスク
JP1723539S (ja) 衛生用マスク
JP1723538S (ja) 衛生用マスク
JP1722551S (ja) 衛生用マスク
JP1716715S (ja) 衛生用マスク